Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +0.08% | +0.24% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Colin S. Dunn
CEO | Chief Executive Officer | - | - |
David Smith
DFI | Director of Finance/CFO | 58 | - |
Maria Pia Muniz
COO | Chief Operating Officer | - | 02-12-31 |
Kalust Ucar
CTO | Chief Tech/Sci/R&D Officer | - | 14-03-31 |
Stephen Minger
PRN | Corporate Officer/Principal | - | - |
Bobbie L. King
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Colin S. Dunn
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,657,206 | 12,860,956 ( 94.17 %) | 0 | 94.17 % |
Company contact information
Charles River Laboratories Cell Solutions, Inc.
8500 Balboa Boulevard Suite 130
91325, Northridge
+
http://www.hemacare.com/Sector
1st Jan change | Capi. | |
---|---|---|
+0.24% | 346M | |
+19.28% | 84.56B | |
-26.95% | 72.41B | |
+4.58% | 27.75B | |
-7.35% | 17.75B | |
-0.46% | 17.11B | |
+4.69% | 16.03B | |
+8.14% | 13.72B | |
+69.96% | 13.07B | |
+6.59% | 12.91B |
- Stock Market
- Equities
- HEMA Stock
- Company HemaCare Corporation